Skip to main content
Skip to footer
Products & Services
AAV
AAV Custom Production
AAV Control Products
AAV Product Catalog
AAV Custom Production
AAV Control Products
AAV Product Catalog
Adenovirus
Adenovirus Construction
Adenovirus Amplification
Adenovirus Control Products
Adenovirus Product Catalog
Adenovirus Construction
Adenovirus Amplification
Adenovirus Control Products
Adenovirus Product Catalog
Other services
shRNA Screening/Validation
shRNA Product Catalog
shRNA Screening/Validation
shRNA Product Catalog
Request A Quote
Applications
Gene Therapy
Disease Modeling
Target Validation
Small Molecule Screening
Gene Therapy
Disease Modeling
Target Validation
Small Molecule Screening
Resources
Understanding Vector Technologies
Citations
Serotype Selection Guide
Promoter Selection Guide
Press Release
FAQs
Product Manuals & MSDS
Understanding Vector Technologies
Citations
Serotype Selection Guide
Promoter Selection Guide
Press Release
FAQs
Product Manuals & MSDS
About Us
Support
Home
Products & Services
About Products & Services
AAV Control Products
AAV Custom Production
AAV Product Catalog
Adenovirus Amplification
Adenovirus Construction
Adenovirus Control Products
Adenovirus Product Catalog
shRNA Screening/Validation
shRNA Product Catalog
Additional QC
Applications
About Applications
Gene Therapy
Disease Modeling
Target Validation
Small Molecule Screening
Resources
About Resources
Understanding Vector Technologies
Citations
Serotype Selection Guide
Promoter Selection Guide
Press Release
FAQs
Product Manuals & MSDS
About Us
Support
Search
Log In
0
Request a Quote
0
Home
/
Citations
/
CRISPR-Cas9–based treatment of myocilin-associated glaucoma
CRISPR-Cas9–based treatment of myocilin-associated glaucoma
A Jain, etc
|
|
University of Iowa
A Jain & etc. (). CRISPR-Cas9–based treatment of myocilin-associated glaucoma.
, doi:
Read Previous Entry
Read Next Entry
Referred Product
